IN202441013791A - - Google Patents

Info

Publication number
IN202441013791A
IN202441013791A IN202441013791A IN202441013791A IN202441013791A IN 202441013791 A IN202441013791 A IN 202441013791A IN 202441013791 A IN202441013791 A IN 202441013791A IN 202441013791 A IN202441013791 A IN 202441013791A IN 202441013791 A IN202441013791 A IN 202441013791A
Authority
IN
India
Application number
IN202441013791A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN202441013791A priority Critical patent/IN202441013791A/en
Priority to PCT/IN2025/050280 priority patent/WO2025181825A2/en
Publication of IN202441013791A publication Critical patent/IN202441013791A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN202441013791A 2024-02-26 2024-02-26 IN202441013791A (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN202441013791A IN202441013791A (enExample) 2024-02-26 2024-02-26
PCT/IN2025/050280 WO2025181825A2 (en) 2024-02-26 2025-02-25 Solid state forms of Elacestrant dihydrochloride and their processes for the preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN202441013791A IN202441013791A (enExample) 2024-02-26 2024-02-26

Publications (1)

Publication Number Publication Date
IN202441013791A true IN202441013791A (enExample) 2025-08-29

Family

ID=96922037

Family Applications (1)

Application Number Title Priority Date Filing Date
IN202441013791A IN202441013791A (enExample) 2024-02-26 2024-02-26

Country Status (2)

Country Link
IN (1) IN202441013791A (enExample)
WO (1) WO2025181825A2 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3565542B1 (en) * 2017-01-05 2024-04-10 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
WO2023064519A1 (en) * 2021-10-14 2023-04-20 Teva Pharmaceuticals International Gmbh Solid state forms of elacestrant and processes for preparation thereof

Also Published As

Publication number Publication date
WO2025181825A2 (en) 2025-09-04
WO2025181825A3 (en) 2025-10-30